Liquidia Corporation Common Stock
LQDA Real Time Price USDRecent trades of LQDA by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by LQDA's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$60,000 Apr 17, 2025 Issue: Health Issues
-
$60,000 Jan 19, 2025 Issue: Health Issues
-
$60,000 Oct 18, 2024 Issue: Health Issues
-
$60,000 Jul 20, 2024 Issue: Health Issues
-
$60,000 Apr 22, 2024 Issue: Health Issues
-
$60,000 Jan 22, 2024 Issue: Health Issues
-
$20,000 Oct 19, 2023 Issue: Health Issues
Estimated quarterly lobbying spending
LQDA Revenue by Segment or Geography
New patents grants
-
Patent Title: Dry powder treprostinil for the treatment of pulmonary hypertension Sep. 05, 2023
-
Patent Title: Dry powder treprostinil for the treatment of pulmonary hypertension Sep. 05, 2023
-
Patent Title: Dry powder treprostinil for the treatment of pulmonary hypertension Aug. 01, 2023
-
Patent Title: Dry powder treprostinil for the treatment of pulmonary hypertension May. 30, 2023
-
Patent Title: Dry powder treprostinil for the treatment of pulmonary hypertension Jan. 26, 2021
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom Jul. 21, 2020
-
Patent Title: Method for producing patterned materials Aug. 29, 2017
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom May. 30, 2017
-
Patent Title: System and method for producing particles and patterned films Jan. 17, 2017
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom May. 17, 2016
-
Patent Title: Nanostructured surfaces for biomedical/biomaterial applications and processes thereof Apr. 19, 2016
-
Patent Title: Method for producing patterned materials Dec. 08, 2015
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom Feb. 03, 2015
-
Patent Title: Nanostructured surfaces for biomedical/biomaterial applications and processes thereof Feb. 03, 2015
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom Mar. 04, 2014
-
Patent Title: System and method for producing particles and patterned films Aug. 27, 2013
-
Patent Title: Method for producing patterned materials May. 21, 2013
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom May. 14, 2013
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom Mar. 06, 2012
-
Patent Title: System and method for producing particles and patterned films Jul. 12, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to LQDA
Recent picks made for LQDA stock on CNBC
ETFs with the largest estimated holdings in LQDA
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $LQDA stock a Buy, Sell, or Hold?
- What is the price target for $LQDA stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $LQDA stock?
- Who owns the most shares of $LQDA stock?
- What funds own $LQDA stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view LQDA Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.